US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

A hospital has launched a specialist "state-of-the-art" £250,000 ophthalmology suite for eye procedures. Kettering General ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

“There’s very clear evidence that screening prevents vision loss,” says Roomasa Channa, a retina specialist at the University of Wisconsin-Madison in the US. In the US barriers include cost, ...

Although eye injections—the most common treatment ... dropping the actual effectiveness rate to about 50%. Diabetic retinopathy is a disease that changes the blood vessels in the retina.

When it comes to type 2 diabetes, using injectables can be the ... and are relatively cost-efficient. The side effects Injections may cause some redness, swelling, changes in skin texture, and ...

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

Therapeutics announced topline interim data from Part 1 of the SPECTRA clinical trial evaluating 4D-150 in diabetic macular ...

He has had 19 eye injections in the last two years to treat diabetic macular oedema – a condition that affects the central sharp vision – and said attending "was quick and easy with free parking".

This required laser treatments and then injections. Eventually the treatments ... In the UK the NHS invites patients, external for diabetic eye screening every one or two years.